Cohen I K
J Trauma. 1985 May;25(5):410-2. doi: 10.1097/00005373-198505000-00006.
Pharmacologic alterations of the inflammatory response and collagen metabolism will lead to control of the many disease states of fibrosis. Many of these diseases kill and cripple far more than hypertrophic scar. Far too little research is being directed in this area. The objectives of controlling fibrosis by interfering with collagen crosslinking were defined clearly by Peacock. Perhaps topical BAPN will be the first agent to bring a practical clinical reality to his predictions made over 20 years ago.
炎症反应和胶原蛋白代谢的药理学改变将有助于控制多种纤维化疾病状态。这些疾病中的许多造成的死亡和残疾远比肥厚性瘢痕严重得多。目前该领域的研究实在太少。Peacock明确了通过干扰胶原蛋白交联来控制纤维化的目标。也许外用β-氨基丙腈(BAPN)将成为首个使他20多年前所做预测成为临床现实的药物。